US20220409047A1 - Apparatus for capturing an image of the eye - Google Patents
Apparatus for capturing an image of the eye Download PDFInfo
- Publication number
- US20220409047A1 US20220409047A1 US17/571,050 US202217571050A US2022409047A1 US 20220409047 A1 US20220409047 A1 US 20220409047A1 US 202217571050 A US202217571050 A US 202217571050A US 2022409047 A1 US2022409047 A1 US 2022409047A1
- Authority
- US
- United States
- Prior art keywords
- imaging device
- image
- eye
- camera
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003384 imaging method Methods 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 23
- 230000002123 temporal effect Effects 0.000 claims description 8
- 230000008961 swelling Effects 0.000 description 50
- 210000000744 eyelid Anatomy 0.000 description 34
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 13
- 230000002618 waking effect Effects 0.000 description 11
- 230000001052 transient effect Effects 0.000 description 10
- 238000011282 treatment Methods 0.000 description 6
- 208000022873 Ocular disease Diseases 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000010217 blepharitis Diseases 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 208000006373 Bell palsy Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 206010068737 Facial asymmetry Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010065062 Meibomian gland dysfunction Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000278713 Theora Species 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940023490 ophthalmic product Drugs 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/14—Arrangements specially adapted for eye photography
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
- G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
- G06V40/18—Eye characteristics, e.g. of the iris
- G06V40/19—Sensors therefor
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/50—Constructional details
- H04N23/51—Housings
-
- H04N5/2252—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/0083—Apparatus for testing the eyes; Instruments for examining the eyes provided with means for patient positioning
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/50—Information retrieval; Database structures therefor; File system structures therefor of still image data
- G06F16/51—Indexing; Data structures therefor; Storage structures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30041—Eye; Retina; Ophthalmic
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/20—ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS
Definitions
- Patients may be afflicted with various ocular diseases including ocular conjunctivitis, blepharitis, dry eye disease, ocular redness or conjunctival hyperemia, eyelid swelling, and morning eyelid congestion (MEC) syndrome. Doctors, scientists, and other medical professionals continue to research treatments for these diseases. However, a large volume of images of patients' eyes are required to properly study these diseases.
- various ocular diseases including ocular conjunctivitis, blepharitis, dry eye disease, ocular redness or conjunctival hyperemia, eyelid swelling, and morning eyelid congestion (MEC) syndrome.
- MEC morning eyelid congestion
- ocular redness or eyelid swelling is a constant condition that does not show any diurnal variation.
- redness or eyelid swelling appears individually and transiently.
- both ocular redness and eyelid swelling appear together in the morning upon awakening and then subside over the morning (this condition is referred to as Morning Eyelid Congestion, MEC), and is transient, can be variable in severity and frequency (number of days it appears), and resolves over the course of the waking day, but is significant, and in cases even detrimental, from the perspective of their own subjective assessment and quality of life.
- MEC Morning Eyelid Congestion
- transient condition e.g. MEC
- the present disclosure provides improved apparatuses that pair with imaging devices to high quality images of the eye from any location. Methods of using the disclosed apparatuses are also provided.
- an apparatus can include a base, a hollow receiving element joined to the base, and at least one positioning attachment.
- the receiving element can be configured to receive an imaging device.
- the at least one positioning attachment can be configured to position the imaging device to capture an image of at least one eye of a user.
- a method of capturing an image of at least one eye of a user can include inserting an imaging device in an apparatus.
- the apparatus can include a base, a hollow receiving element joined to the base, and at least one positioning attachment.
- the receiving element can be configured to receive an imaging device.
- the at least one positioning attachment can be configured to position the imaging device to capture an image of at least one eye of a user.
- the method can further include capturing at least one image of the at least one eye of the user.
- FIG. 1 is a perspective view of an apparatus for receiving an imaging device configured to capture a front image of a patient's eyes according to various exemplary embodiments.
- FIG. 2 is a perspective view of the apparatus for receiving an imaging device configured to capture 90° temporal side image of a patient's eyes according to various exemplary embodiments.
- FIG. 3 is a perspective view of a case for an imaging device according to various exemplary embodiments.
- FIG. 4 depicts a method of capturing images of a patient's eye(s) according to various exemplary embodiments.
- FIG. 5 is a graph illustrating mean lid swelling and redness values recorded from subjects in Example 1, as captured by the disclosed apparatus.
- FIG. 6 is a chart depicting the percentage of days that subjects in Example 1 experienced lid swelling, conjunctival redness, or both, as captured by the disclosed apparatus.
- FIG. 7 depicts lid swelling data of two subjects in Example 1 as captured by the disclosed apparatus.
- Disclosed herein is an apparatus that enables individuals to capture images of their own eyes with an imaging device such as a smartphone.
- FIG. 1 is a perspective view of an apparatus for receiving an imaging device to capture images of a patient's eyes according to various exemplary embodiments.
- the apparatus 100 includes a base 110 , a hollow receiving element 120 , and a positioning attachment 130 .
- the apparatus 100 is configured to receive an imaging device and capture an image of at least one of a user's eyes.
- the base 110 is configured to provide support and balance the apparatus 100 .
- the base may include multiple extensions 112 extending radially from the center of the base 110 .
- a base 110 with four extensions 112 is depicted in FIG. 1 .
- the base 110 is configured to join with a hollow element 120 .
- the base 110 and hollow element 120 are permanently joined, for example by soldering.
- the base 110 and the hollow element 120 are removably joined.
- the base 110 and the hollow element 120 may be joined by a fitted connection or magnetic connection.
- the hollow element 120 is configured to receive an imaging device (not depicted).
- the imaging device may be any device capable of capturing images of sufficient quality for ocular disease research.
- the imaging device is a smartphone, such as an iPhone®, Galaxy®, Droid®, and the like.
- the hollow element 120 magnetically connects to the imaging device or a case around the imaging device.
- the hollow element 120 is a sufficient depth and width to receive the imaging device.
- the hollow element 120 may be a depth ranging from 1 inch to 24 inches, or any depth in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the hollow element 120 may have a diameter ranging from 1 inch to 24 inches, or any diameter in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the hollow element is adjustable and extendible.
- the positioning attachment 130 is configured to position the imaging device within the apparatus 100 to enable a photo of a user's eyes from a front view.
- the positioning attachment 130 is removably joined to the hollow element 120 .
- the positioning attachment 130 and the hollow element 120 may be joined by a fitted connection or magnetic connection.
- the positioning attachment 130 is substantially circular and has first portion 132 and a second portion 134 .
- the first portion 132 is shorter than the second portion 130 .
- the first portion 132 is positioned in front of a camera of the imaging device.
- the second portion 134 is positioned on the opposite side of the camera of the imaging device.
- the second portion 134 is of sufficient height to support the imaging device and prevent movement of the imaging device while in use.
- the first portion 132 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the second portion 134 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the positioning attachment 130 may have a diameter ranging from 1 inch to 24 inches, or any diameter in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- FIG. 2 is a perspective view of the apparatus for receiving an imaging device to capture a 90° temporal side image of at least one of a patient's eyes according to various exemplary embodiments.
- the apparatus 200 includes a base 210 , a hollow receiving element 220 , and a positioning attachment 230 .
- the apparatus 200 is similar to that of apparatus 100 except the positioning attachment 230 is configured to position an imaging device to capture a 90° temporal side image of at least one of a patient's eyes.
- the positioning attachment 230 has a first portion 232 and a second portion 234 .
- the first portion 132 is shorter than the second portion 130 .
- the first portion 132 is positioned in front of a camera of the imaging device.
- the second portion 134 is positioned on the opposite side of the camera of the imaging device but may extend over or beyond the center of the imaging device towards the camera side of the imaging device.
- the first portion 132 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the second portion 134 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the positioning attachment 130 may have a diameter ranging from 1 inch to 24 inches, or any diameter in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches.
- the portion of the positioning attachment 230 including the second portion 234 may extend medially towards the center of the apparatus 200 at an angle.
- the angle may range from 1 degree to 90 degrees, or any degree in between. In an embodiment, the angle is 90°.
- the imaging device is a smartphone.
- the smartphone may include an application designed to instruct a user through an imaging process.
- the application may include directions on how to assemble the device and how to place the smartphone within the apparatus.
- the application may also utilize the smartphone's camera directly and include optimal parameters for capturing images. Such optimal parameters may be brightness, strength of flash, number of pixels, filters, and the like.
- the application transmits captured images to a database for review by scientists and/or medical professionals.
- FIG. 3 is a perspective view of a case for an imaging device according to various exemplary embodiments.
- the case 300 is sized to snugly fit around an imaging device (not shown).
- the imaging device is a smartphone, such as an iPhone®, Galaxy®, Droid®, and the like. Magnets may be located throughout, within, or attached to the case 300 .
- the case 300 is configured to be inserted within a hollow element of an apparatus.
- the case 300 may be removably secured within the hollow element.
- the case 300 is magnetically connected to the hollow element.
- the position of the case 300 is adjustable and may be determined by a positioning attachment of the apparatus.
- the case 300 includes at least one aperture 310 to provide an opening for a camera of the imaging device.
- the aperture 310 is located within the case 300 relative to the imaging device the case 300 is designed for.
- a case 300 for a Samsung Galaxy S5® would include an aperture 310 along the center longitudinal axis of the case 300 near the top lateral edge of the case 300 .
- FIG. 4 depicts a method 400 of capturing images of a patient's eye(s).
- the method may be performed by the patient or by another user.
- the method begins at step 410 when an apparatus is assembled to receive an imaging device.
- an imaging device is inserted into the apparatus.
- the imaging device may be secured via physical contact with the apparatus.
- the imaging device is a smartphone.
- the at least one image may be a front image of the patient's eye(s), a fixed-perspective image of the peri-ocular region, or other image of at least one eye.
- the at least one image allows clinicians to evaluate the subjective assessments of swelling provided by patients while providing a system and method for controlled, repeatable, at-home imaging that could be used for clinician confirmation of a condition.
- the subjective assessments can be recorded in a patient diary.
- the subjective assessments can include patient comfort, quality of life, and the like.
- the patient diary can be recorded in the imaging device.
- the patient diary can be set with reminders to ensure compliance of recording the subjective assessments, dosing of drugs (if applicable) and other notices.
- the at least one image may be transmitted to a database after the at least one image is taken.
- the imaging device and a first supporting attachment of the apparatus are removed from the apparatus.
- a second supporting attachment is attached to the apparatus.
- the first supporting attachment may be configured to position the imaging device to capture a front image of at least one of a patient's eyes.
- the second supporting attachment may be configured to position the imaging device to capture a 90° temporal side image of at least one of a patient's eyes.
- the imaging device is reinserted into the apparatus. Then at step 470 at least one image of 90° temporal side image of at least one of a patient's eyes is captured.
- the method concludes at step 480 when all images taken are sent to a database for review by scientists, clinicians, and/or medical professionals.
- Example 1 describes a single-center, three-week study evaluating the frequency, severity, and duration of morning eyelid congestion in an environmental setting using the at-home electronic diary and eyelid image capture system. All subjects were 18 years of age or older, provided informed consent, and were willing and able to follow all instructions. Slit lamp biomicroscopy examinations and visual acuity assessments were conducted at each study visit. Subjects for the study were required to satisfy inclusion criteria at both baseline (Visit 1 ) and following a 6-day screening period (Visit 2).
- Exclusion criteria included active ocular infection or inflammation, active blepharitis, meibomian gland dysfunction, ocular allergies that required therapeutic treatment, marked facial asymmetry, ptosis, significant dermatochalasis, deep dermal scarring, history of facial nerve palsy, prior blepharoplasty, use of any cosmetics marketed for reduction of eyelid swelling, history of ocular surgical procedure within 12 months, and use of any topical ocular medications within 24 hours prior to Visit 1 or for the duration of the study other than artificial tear substitutes.
- subjects with any uncontrolled systemic disease, or any condition that, in the opinion of the investigator, could confound the study results were also excluded.
- Subjects satisfying entry criteria were provided the disclosed apparatus. They were asked to capture lid images (1 image from front and 1 image from temporal side for each eye) and grade their eyelid swelling and conjunctival redness (0-4 scale) during the evening, upon waking, 30 minutes after waking, and at 1, 2, 3, 4, 5, and 6 hours after waking for the next six days.
- All subjects at Visit 2 were required to demonstrate each of the following: (1) at least 1 day of eyelid swelling in the diary graded as a 3 or higher in at least one eye; (2) at least 1 day of eyelid swelling in the diary that resolved 2 or more hours after awakening; (3) at least one episode of clinician-verified present lid swelling (as recorded in diary and in images reviewed by the physician) corresponding to a grade of (0-4 scale).
- Subjects satisfying inclusion criteria at Visit 2 proceeded in the study and used the disclosed apparatus for an additional 14 days, capturing lid images and grading their eyelid swelling and conjunctival redness (0-4 scale) in a similar manner (evening, upon waking, 30 minutes after waking, and at 1, 2, 3, 4, 5, and 6 hours after waking).
- Visit 2 Day 7 ⁇ 2
- the subject's diary recordings were reviewed.
- a total of 22 of the 29 subjects satisfied inclusion criteria at Visit 2 and proceeded to Visit 3 (Day 21 ⁇ 2).
- Visit 3 Day 21 ⁇ 2
- the screening process demonstrates the utility of using the eyelid image capturing and diary system to capture images and subjective assessment that can be reviewed by a clinician at an office visit.
- the mean lid swelling values recorded from the subjects are illustrated in FIG. 5 .
- the mean lid swelling scores upon awakening for all 22 subjects over the 20 days of observation was 2.64 ⁇ 0.55.
- the mean lid swelling score at evening was 1.44 ⁇ 0.65; the mean lid swelling scores at 6 hours post awakening was 1.53 ⁇ 0.49, similar to the evening scores.
- the conjunctival redness scores followed a pattern similar to that of lid swelling.
- the scores were maximal upon waking, with a mean of 1.83 ⁇ 0.97.
- the lowest scores for redness were observed in the evening, with a mean of 0.51 ⁇ 0.65.
- the mean conjunctival redness score at 6 hours post awakening was 1.05 ⁇ 0.94.
- Seventeen (77.3%) of the 22 enrolled subjects showed a transient conjunctival redness that improved within 1-6 hours of awakening. Among these subjects, this transient redness was reported on most days (mean of 12 ⁇ 8 days) over the course of the 20-day study. In the remaining 5 subjects, 2 did not exhibit redness and 3 had persistent redness throughout the 6 hour observation period post-awakening.
- FIG. 6 shows the percentage of days (from a total of 20 study days) that subjects experienced lid swelling, conjunctival redness, or both. Day-to-day variability was evident between subjects, with MEC present in approximately a third of subjects on at least 75% of days during the study.
- the study provides the basis for identification of a well-defined population of individuals who experience MEC: a transient, self-resolving edema of the peri-ocular region in combination with a mild to moderate conjunctival hyperemia.
- the successful application of the disclosed apparatus provided the tools necessary to assess MEC, and any potential treatments that may provide therapeutic benefit for MEC, in a well-designed, controlled study.
- the objective of this study was to refine the methods used to characterize MEC in the hope that a distinct population (or populations) of subjects report this condition could be identified based upon a shared symptomology. Two distinct populations have been distinguished along with a set of endpoints that allows clinicians to further characterize and properly select those to treat with MEC based on data captured with the disclosed apparatus.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Theoretical Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Multimedia (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Signal Processing (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Quality & Reliability (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Human Computer Interaction (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
- This application is a continuation application of U.S. patent application Ser. No. 15/837,712, filed on Dec. 11, 2017, which claims the benefit of and priority to U.S. Provisional Application No. 62/432,429, filed on Dec. 9, 2016, the contents of each of which are incorporated herein by reference in their entireties.
-
-
- capturing images of eyes utilizing an imaging device such as a smartphone. The captured images are used to study ocular diseases.
- Patients may be afflicted with various ocular diseases including ocular conjunctivitis, blepharitis, dry eye disease, ocular redness or conjunctival hyperemia, eyelid swelling, and morning eyelid congestion (MEC) syndrome. Doctors, scientists, and other medical professionals continue to research treatments for these diseases. However, a large volume of images of patients' eyes are required to properly study these diseases.
- For example, for some patients, ocular redness or eyelid swelling is a constant condition that does not show any diurnal variation. For other patients, redness or eyelid swelling appears individually and transiently. For other patients, both ocular redness and eyelid swelling appear together in the morning upon awakening and then subside over the morning (this condition is referred to as Morning Eyelid Congestion, MEC), and is transient, can be variable in severity and frequency (number of days it appears), and resolves over the course of the waking day, but is significant, and in cases even detrimental, from the perspective of their own subjective assessment and quality of life. The distinction between a persistent condition and one that is transient, resolving from morning through the day, may lead to different approaches for treatment. Proper capture of the severity and frequency of these conditions is needed and it is therefore important to properly characterize the profile of these patients with a transient condition (e.g. MEC) that consists of both swelling and redness, or either alone, because clinical assessment by a physician in the office may not properly capture the severity of transient conditions.
- Useful images of the eyes must be precise, reproducible, and taken from a number of angles. In order to acquire images of the desired quality, current solutions require photographers to take images of patients' eyes in a controlled setting. This limits the number of times images can be taken and places a logistical and a financial burden on research into ocular disease.
- The present disclosure provides improved apparatuses that pair with imaging devices to high quality images of the eye from any location. Methods of using the disclosed apparatuses are also provided.
- According to certain embodiments, an apparatus is provided. The apparatus can include a base, a hollow receiving element joined to the base, and at least one positioning attachment. The receiving element can be configured to receive an imaging device. The at least one positioning attachment can be configured to position the imaging device to capture an image of at least one eye of a user.
- According to certain embodiments, a method of capturing an image of at least one eye of a user is provided. The method can include inserting an imaging device in an apparatus. The apparatus can include a base, a hollow receiving element joined to the base, and at least one positioning attachment. The receiving element can be configured to receive an imaging device. The at least one positioning attachment can be configured to position the imaging device to capture an image of at least one eye of a user. The method can further include capturing at least one image of the at least one eye of the user.
-
FIG. 1 is a perspective view of an apparatus for receiving an imaging device configured to capture a front image of a patient's eyes according to various exemplary embodiments. -
FIG. 2 is a perspective view of the apparatus for receiving an imaging device configured to capture 90° temporal side image of a patient's eyes according to various exemplary embodiments. -
FIG. 3 is a perspective view of a case for an imaging device according to various exemplary embodiments. -
FIG. 4 depicts a method of capturing images of a patient's eye(s) according to various exemplary embodiments. -
FIG. 5 is a graph illustrating mean lid swelling and redness values recorded from subjects in Example 1, as captured by the disclosed apparatus. -
FIG. 6 is a chart depicting the percentage of days that subjects in Example 1 experienced lid swelling, conjunctival redness, or both, as captured by the disclosed apparatus. -
FIG. 7 depicts lid swelling data of two subjects in Example 1 as captured by the disclosed apparatus. - Reference will now be made in detail to certain exemplary embodiments according to the present disclosure, certain examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
- In this application, the use of the singular includes the plural unless specifically stated otherwise. In this application, the use of “or” means “and/or” unless stated otherwise. Furthermore, the use of the term “including”, as well as other forms, such as “includes” and “included”, is not limiting. Any range described herein will be understood to include the endpoints and all values between the endpoints.
- The section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described. All documents, or portions of documents, cited in this application, including but not limited to patents, patent applications, articles, books, and treatises, are hereby expressly incorporated by reference in their entirety for any purpose.
- Disclosed herein is an apparatus that enables individuals to capture images of their own eyes with an imaging device such as a smartphone.
-
FIG. 1 is a perspective view of an apparatus for receiving an imaging device to capture images of a patient's eyes according to various exemplary embodiments. Theapparatus 100 includes abase 110, ahollow receiving element 120, and apositioning attachment 130. Theapparatus 100 is configured to receive an imaging device and capture an image of at least one of a user's eyes. - The
base 110 is configured to provide support and balance theapparatus 100. The base may includemultiple extensions 112 extending radially from the center of thebase 110. Abase 110 with fourextensions 112 is depicted inFIG. 1 . - The
base 110 is configured to join with ahollow element 120. In some embodiments, thebase 110 andhollow element 120 are permanently joined, for example by soldering. In some embodiments, thebase 110 and thehollow element 120 are removably joined. For example, thebase 110 and thehollow element 120 may be joined by a fitted connection or magnetic connection. - The
hollow element 120 is configured to receive an imaging device (not depicted). The imaging device may be any device capable of capturing images of sufficient quality for ocular disease research. In some embodiments, the imaging device is a smartphone, such as an iPhone®, Galaxy®, Droid®, and the like. In some embodiments, thehollow element 120 magnetically connects to the imaging device or a case around the imaging device. - The
hollow element 120 is a sufficient depth and width to receive the imaging device. Thehollow element 120 may be a depth ranging from 1 inch to 24 inches, or any depth in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. Thehollow element 120 may have a diameter ranging from 1 inch to 24 inches, or any diameter in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. In some embodiments, the hollow element is adjustable and extendible. - The
positioning attachment 130 is configured to position the imaging device within theapparatus 100 to enable a photo of a user's eyes from a front view. Thepositioning attachment 130 is removably joined to thehollow element 120. For example, thepositioning attachment 130 and thehollow element 120 may be joined by a fitted connection or magnetic connection. - The
positioning attachment 130 is substantially circular and hasfirst portion 132 and asecond portion 134. Thefirst portion 132 is shorter than thesecond portion 130. Thefirst portion 132 is positioned in front of a camera of the imaging device. Thesecond portion 134 is positioned on the opposite side of the camera of the imaging device. Thesecond portion 134 is of sufficient height to support the imaging device and prevent movement of the imaging device while in use. - The
first portion 132 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. Thesecond portion 134 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. Thepositioning attachment 130 may have a diameter ranging from 1 inch to 24 inches, or any diameter in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. -
FIG. 2 is a perspective view of the apparatus for receiving an imaging device to capture a 90° temporal side image of at least one of a patient's eyes according to various exemplary embodiments. The apparatus 200 includes abase 210, ahollow receiving element 220, and apositioning attachment 230. - The apparatus 200 is similar to that of
apparatus 100 except thepositioning attachment 230 is configured to position an imaging device to capture a 90° temporal side image of at least one of a patient's eyes. Thepositioning attachment 230 has afirst portion 232 and asecond portion 234. Thefirst portion 132 is shorter than thesecond portion 130. Thefirst portion 132 is positioned in front of a camera of the imaging device. Thesecond portion 134 is positioned on the opposite side of the camera of the imaging device but may extend over or beyond the center of the imaging device towards the camera side of the imaging device. - The
first portion 132 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. Thesecond portion 134 may have a height ranging from 1 inch to 24 inches, or any height in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. Thepositioning attachment 130 may have a diameter ranging from 1 inch to 24 inches, or any diameter in between such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, or 24 inches. - The portion of the
positioning attachment 230 including thesecond portion 234 may extend medially towards the center of the apparatus 200 at an angle. The angle may range from 1 degree to 90 degrees, or any degree in between. In an embodiment, the angle is 90°. - In some embodiments, the imaging device is a smartphone. The smartphone may include an application designed to instruct a user through an imaging process. The application may include directions on how to assemble the device and how to place the smartphone within the apparatus. The application may also utilize the smartphone's camera directly and include optimal parameters for capturing images. Such optimal parameters may be brightness, strength of flash, number of pixels, filters, and the like. In some embodiments, the application transmits captured images to a database for review by scientists and/or medical professionals.
-
FIG. 3 is a perspective view of a case for an imaging device according to various exemplary embodiments. Thecase 300 is sized to snugly fit around an imaging device (not shown). In some embodiments, the imaging device is a smartphone, such as an iPhone®, Galaxy®, Droid®, and the like. Magnets may be located throughout, within, or attached to thecase 300. - The
case 300 is configured to be inserted within a hollow element of an apparatus. Thecase 300 may be removably secured within the hollow element. In some embodiments, thecase 300 is magnetically connected to the hollow element. The position of thecase 300 is adjustable and may be determined by a positioning attachment of the apparatus. - The
case 300 includes at least oneaperture 310 to provide an opening for a camera of the imaging device. Theaperture 310 is located within thecase 300 relative to the imaging device thecase 300 is designed for. As a non-limiting example, acase 300 for a Samsung Galaxy S5® would include anaperture 310 along the center longitudinal axis of thecase 300 near the top lateral edge of thecase 300. -
FIG. 4 depicts amethod 400 of capturing images of a patient's eye(s). The method may be performed by the patient or by another user. The method begins atstep 410 when an apparatus is assembled to receive an imaging device. Then, atstep 420 an imaging device is inserted into the apparatus. The imaging device may be secured via physical contact with the apparatus. In some embodiments, the imaging device is a smartphone. - Next at
step 430 at least one image of a patient's eye(s) is captured by the imaging device. The at least one image may be a front image of the patient's eye(s), a fixed-perspective image of the peri-ocular region, or other image of at least one eye. The at least one image allows clinicians to evaluate the subjective assessments of swelling provided by patients while providing a system and method for controlled, repeatable, at-home imaging that could be used for clinician confirmation of a condition. The subjective assessments can be recorded in a patient diary. The subjective assessments can include patient comfort, quality of life, and the like. In some embodiments, the patient diary can be recorded in the imaging device. The patient diary can be set with reminders to ensure compliance of recording the subjective assessments, dosing of drugs (if applicable) and other notices. Atoptional step 435, the at least one image may be transmitted to a database after the at least one image is taken. - Then at
step 440 the imaging device and a first supporting attachment of the apparatus are removed from the apparatus. Next at step 450 a second supporting attachment is attached to the apparatus. The first supporting attachment may be configured to position the imaging device to capture a front image of at least one of a patient's eyes. The second supporting attachment may be configured to position the imaging device to capture a 90° temporal side image of at least one of a patient's eyes. - After the second supporting attachment is attached, at
step 460 the imaging device is reinserted into the apparatus. Then atstep 470 at least one image of 90° temporal side image of at least one of a patient's eyes is captured. The method concludes atstep 480 when all images taken are sent to a database for review by scientists, clinicians, and/or medical professionals. - Example 1 describes a single-center, three-week study evaluating the frequency, severity, and duration of morning eyelid congestion in an environmental setting using the at-home electronic diary and eyelid image capture system. All subjects were 18 years of age or older, provided informed consent, and were willing and able to follow all instructions. Slit lamp biomicroscopy examinations and visual acuity assessments were conducted at each study visit. Subjects for the study were required to satisfy inclusion criteria at both baseline (Visit 1) and following a 6-day screening period (Visit 2).
- To satisfy inclusion criteria at
Visit 1, all subjects were required to self-report morning eyelid congestion (i.e. both conjunctival redness and eyelid swelling) that (1) lasted for at least 2 hours after waking, (2) had occurred at least 3 days in the prior week and (3) had an in-office, retrospective subjective grade of eyelid edema of at least 3 (on a 0-4 scale) upon awakening, on at least one day. Exclusion criteria included active ocular infection or inflammation, active blepharitis, meibomian gland dysfunction, ocular allergies that required therapeutic treatment, marked facial asymmetry, ptosis, significant dermatochalasis, deep dermal scarring, history of facial nerve palsy, prior blepharoplasty, use of any cosmetics marketed for reduction of eyelid swelling, history of ocular surgical procedure within 12 months, and use of any topical ocular medications within 24 hours prior to Visit 1 or for the duration of the study other than artificial tear substitutes. In addition, subjects with any uncontrolled systemic disease, or any condition that, in the opinion of the investigator, could confound the study results were also excluded. - Subjects satisfying entry criteria were provided the disclosed apparatus. They were asked to capture lid images (1 image from front and 1 image from temporal side for each eye) and grade their eyelid swelling and conjunctival redness (0-4 scale) during the evening, upon waking, 30 minutes after waking, and at 1, 2, 3, 4, 5, and 6 hours after waking for the next six days.
- All subjects at
Visit 2 were required to demonstrate each of the following: (1) at least 1 day of eyelid swelling in the diary graded as a 3 or higher in at least one eye; (2) at least 1 day of eyelid swelling in the diary that resolved 2 or more hours after awakening; (3) at least one episode of clinician-verified present lid swelling (as recorded in diary and in images reviewed by the physician) corresponding to a grade of (0-4 scale). Subjects satisfying inclusion criteria atVisit 2 proceeded in the study and used the disclosed apparatus for an additional 14 days, capturing lid images and grading their eyelid swelling and conjunctival redness (0-4 scale) in a similar manner (evening, upon waking, 30 minutes after waking, and at 1, 2, 3, 4, 5, and 6 hours after waking). - Primary evaluation measures were subject-graded global eyelid swelling (on a 0 to 4 scale in which 0=no lid swelling and 4=severe lid swelling) and conjunctival redness (0 to 4 scale, with 0=no redness and 4=severe redness). Secondary measures included subject-graded regional eyelid swelling (0-4 scale per region) and a lid swelling questionnaire. Safety measures included adverse event query, best-corrected visual acuity, and slit lamp biomicroscopy. Symptoms were evaluated with a lid swelling questionnaire, a lid swelling scale, and conjunctival redness scale using the Ora Calibra™ scales.
- At home, subjects used a diary system to capture two photographs of each eye, and to evaluate symptoms the prior evening, upon awakening, after 30 minutes, and hourly from 1 to 6 hours after awakening using the same grading systems described above for the screening period.
- A total of 29 subjects satisfied inclusion criteria at
Visit 1 and were provided an electronic diary and the disclosed apparatus for the 6-day screening period. At Visit 2 (Day 7±2), the subject's diary recordings were reviewed. A total of 22 of the 29 subjects satisfied inclusion criteria atVisit 2 and proceeded to Visit 3 (Day 21±2). Of those subjects who were discontinued atVisit 2, two were unable or unwilling to use the disclosed apparatus, two were judged by clinicians to not have lid swelling based on the diary images, and three did not report at least 1 day with swelling score of sufficient severity. The screening process demonstrates the utility of using the eyelid image capturing and diary system to capture images and subjective assessment that can be reviewed by a clinician at an office visit. - The mean lid swelling values recorded from the subjects are illustrated in
FIG. 5 . The mean lid swelling scores upon awakening for all 22 subjects over the 20 days of observation was 2.64±0.55. The mean lid swelling score at evening was 1.44±0.65; the mean lid swelling scores at 6 hours post awakening was 1.53±0.49, similar to the evening scores. - Of the 22 subjects enrolled, 19 (86.4%) demonstrated a pattern of transient lid swelling that improved steadily in the 1-6 hours after awakening. In these 19 individuals, morning lid swelling was observed on the majority (mean of 15±4 days) of the 20 days of observation. In 3 subjects, lid swelling of similar severity remained present for the entire 6 hour observation window.
- As seen in
FIG. 5 , the conjunctival redness scores followed a pattern similar to that of lid swelling. The scores were maximal upon waking, with a mean of 1.83±0.97. The lowest scores for redness were observed in the evening, with a mean of 0.51±0.65. The mean conjunctival redness score at 6 hours post awakening was 1.05±0.94. Seventeen (77.3%) of the 22 enrolled subjects showed a transient conjunctival redness that improved within 1-6 hours of awakening. Among these subjects, this transient redness was reported on most days (mean of 12±8 days) over the course of the 20-day study. In the remaining 5 subjects, 2 did not exhibit redness and 3 had persistent redness throughout the 6 hour observation period post-awakening. - Overall, 16 (72.7%) of 22 subjects exhibited both eyelid swelling and redness which peaked upon wakening and slowly resolved over the course of 1-6 hours. This subgroup of 16 subjects satisfied the criteria defined for the condition of morning eyelid congestion (MEC).
- A notable feature of MEC is its sporadic nature.
FIG. 6 shows the percentage of days (from a total of 20 study days) that subjects experienced lid swelling, conjunctival redness, or both. Day-to-day variability was evident between subjects, with MEC present in approximately a third of subjects on at least 75% of days during the study. - Among those individuals who self-identified with MEC, the overwhelming majority (86.4%) of subjects demonstrated a pattern of transient symptomatology over the course of the waking hours. In addition, 3 subjects (13.6%) who self-reported lid swelling had a persistent lid swelling which was similar in severity across evening, upon awakening, and over the course of the first 6 waking hours. In contrast, the majority of the study population displayed the pattern of decreased swelling and hyperemia over the course of the day. Lid swelling patterns of two subjects with different patterns are depicted in
FIG. 7 . - A quality of life survey of subjects who had self-identified as experiencing some degree of MEC was also conducted to assess subjective aspects of the condition. The results of the survey are depicted in Table 1.
-
TABLE 1 Yes No Has your eyelid swelling or eyelid puffiness ever 57% 43% caused you to apply make-up? Has your eyelid swelling or eyelid puffiness ever 47% 53% caused a loss in self-confidence? Has your eyelid swelling or eyelid puffiness ever 23% 77% impacted your daily routine? Has your eyelid swelling or eyelid puffiness ever 63% 37% caused an increase in time to get ready in the morning? When does eyelid swelling occur? 37% Everyday 53% Most Days 10% Some Days 0% Never - A high percentage of subjects (90%) reported that they suffered MEC “everyday” or “most days”. In addition, a majority of respondents reported that their MEC impacted daily routines such as morning preparation times (63%).
- The study provides the basis for identification of a well-defined population of individuals who experience MEC: a transient, self-resolving edema of the peri-ocular region in combination with a mild to moderate conjunctival hyperemia. A majority of those in the study (73%) who experience a morning eyelid swelling have MEC, while others (14%) experience a separate, more persistent condition likely due to a distinct set of underlying factors. In addition, the successful application of the disclosed apparatus provided the tools necessary to assess MEC, and any potential treatments that may provide therapeutic benefit for MEC, in a well-designed, controlled study.
- The objective of this study was to refine the methods used to characterize MEC in the hope that a distinct population (or populations) of subjects report this condition could be identified based upon a shared symptomology. Two distinct populations have been distinguished along with a set of endpoints that allows clinicians to further characterize and properly select those to treat with MEC based on data captured with the disclosed apparatus.
- In the study, roughly three quarters (16/22; 72.7%) of the subjects who self-reported MEC observed gradable lid swelling and redness at 2 or more days over a 20 day observation period. In these subjects, most experienced MEC sporadically. This finding suggests that even in a self-defined population who suffers from this condition, MEC presents only sporadically in most subjects. This point emphasizes the importance of extended periods of observation when attempting to study and profile the frequency and severity of MEC experienced by each individual. Furthermore, the presence of both redness and swelling in the majority of this population suggests that both are essential diagnostic criteria.
- Individuals recruited for this study were all self-reported as experiencing the combination of frequent eyelid puffiness and conjunctival redness upon awakening. The impact of this condition was explored in a brief quality of life survey, in which subjects report a disruption of morning routines and an impact on attitudes regarding personal appearance; for these individuals, 90% report that they experience MEC all or most mornings. These numbers reflect the impact that MEC has on subjects' self-image, since the data suggest that measurable MEC occurs for this group about 50% of the time. This initial assessment suggests that treatments to reduce severity or frequency of MEC in those susceptible to it would have a substantial, positive impact on quality of life and self-image. It also demonstrates the importance of proper characterization of these patient populations to properly identify those that report and exhibit significant eyelid swelling and redness (morning eyelid congestion-MEC). The characterization and definition of the condition presented here provides important guidance in future efforts to develop such treatments. In particular, characterization of the MEC condition in this study was driven by the ability to collect data from an at-home diary based electronic system that supports patient compliance and facilitated data collection of both subjective scoring as well as images that were used by physicians to confirm presence of the condition for enrollment. This study also demonstrated that even in patients who report redness and swelling, not all have a verified condition. Further, the eyelid image capturing system was able to properly capture an actual frequency and severity and identify patients who have MEC, which is both redness and swelling together that is transient.
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/571,050 US20220409047A1 (en) | 2016-12-09 | 2022-01-07 | Apparatus for capturing an image of the eye |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662432429P | 2016-12-09 | 2016-12-09 | |
US15/837,712 US11246483B2 (en) | 2016-12-09 | 2017-12-11 | Apparatus for capturing an image of the eye |
US17/571,050 US20220409047A1 (en) | 2016-12-09 | 2022-01-07 | Apparatus for capturing an image of the eye |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/837,712 Continuation US11246483B2 (en) | 2016-12-09 | 2017-12-11 | Apparatus for capturing an image of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220409047A1 true US20220409047A1 (en) | 2022-12-29 |
Family
ID=62487652
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/837,712 Active US11246483B2 (en) | 2016-12-09 | 2017-12-11 | Apparatus for capturing an image of the eye |
US17/571,050 Abandoned US20220409047A1 (en) | 2016-12-09 | 2022-01-07 | Apparatus for capturing an image of the eye |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/837,712 Active US11246483B2 (en) | 2016-12-09 | 2017-12-11 | Apparatus for capturing an image of the eye |
Country Status (1)
Country | Link |
---|---|
US (2) | US11246483B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD875946S1 (en) * | 2016-12-09 | 2020-02-18 | Ora, Inc. | Apparatus for capturing an image of the eye |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090109327A1 (en) * | 2007-10-24 | 2009-04-30 | Hon Hai Precision Industry Co., Ltd. | Camera module |
US20160073877A1 (en) * | 2012-02-02 | 2016-03-17 | Wei Su | Eye imaging apparatus and systems |
US20160209733A1 (en) * | 2015-01-19 | 2016-07-21 | Yoshiko Akai | Holder for mobile devices to take self-portraits or selfies remotely |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1859756A (en) | 1929-03-25 | 1932-05-24 | American Optical Corp | Eye examining instrument |
US1852837A (en) | 1930-01-13 | 1932-04-05 | American Optical Corp | Eye examining instrument |
US2132520A (en) | 1937-02-13 | 1938-10-11 | Educational Lab Inc | Means and method of recording eye movements |
US2229721A (en) | 1937-10-04 | 1941-01-28 | Look Inc | Camera for recording eye movements |
US2826194A (en) | 1955-11-07 | 1958-03-11 | Golden Seymour | Liquid applicator |
US3026522A (en) | 1958-07-02 | 1962-03-27 | Julio Carl J Di | Diving helmet |
US2920624A (en) | 1958-07-31 | 1960-01-12 | Gillette Co | Eye drop dispenser |
US3016898A (en) | 1959-09-08 | 1962-01-16 | Weldon C Erwin | Combination eye cup and eye fluid applicator |
US3200817A (en) | 1961-12-05 | 1965-08-17 | Benson C Brainard | Spray container shield enclosure |
US3279466A (en) | 1963-06-19 | 1966-10-18 | Dwain E Mings | Eye drop aid for administering ophthalmic solution without excessive head tilting |
US3314426A (en) | 1964-05-20 | 1967-04-18 | Lever Brothers Ltd | Eyecup and spray dispenser |
US3602217A (en) | 1969-04-15 | 1971-08-31 | Richard Dupont | Eye treatment device |
US3934590A (en) | 1974-11-21 | 1976-01-27 | Campagna Gary J | Ocular positioning droplet dispensing device |
USD244670S (en) | 1975-01-30 | 1977-06-14 | Winikoff Stuart F | Dispensing cap for an eye drop bottle or the like |
US5382243A (en) | 1993-09-14 | 1995-01-17 | Mulholland; Adrian | Apparatus with indicator for administration of eye medication |
USD403399S (en) | 1997-01-09 | 1998-12-29 | Montgomery Noel P | Eye drop guidance device |
USD413668S (en) | 1997-06-02 | 1999-09-07 | Pharmacia & Upjohn Ab | Aid device for applying eye drops |
USD444874S1 (en) | 2000-07-31 | 2001-07-10 | Allergan Sales, Inc. | Self instill twist housing eye drop dispenser |
JP2004065854A (en) | 2002-08-09 | 2004-03-04 | Wayoo Kk | Stand for cellular phone |
USD502771S1 (en) | 2003-02-05 | 2005-03-08 | Moosa Elsa Moosa Al Amri | Combined eye-wash container and removable cover |
JP2004261316A (en) | 2003-02-28 | 2004-09-24 | Matsushita Electric Ind Co Ltd | Ocular diagnostic system |
JP2005094792A (en) | 2004-10-29 | 2005-04-07 | Yoshishige Araki | Mobile phone stand for vehicle |
TWM363768U (en) | 2009-03-10 | 2009-08-21 | Chenming Mold Ind Corp | Digital mobile device and its supporting stand module |
US8262221B2 (en) | 2009-04-24 | 2012-09-11 | Filar Paul A | Ophthalmological diagnostic system |
JP3155214U (en) | 2009-07-08 | 2009-11-12 | 山本 孝 | Stand for mobile phone photography |
USD633617S1 (en) | 2009-10-30 | 2011-03-01 | Field Optics Research, Inc. | Eye shroud |
GB201002248D0 (en) | 2010-02-10 | 2010-03-31 | Lawton Thomas A | An attachment for a personal communication device |
KR20120140324A (en) | 2011-06-21 | 2012-12-31 | 정하철 | Capture apparatus |
US8746638B2 (en) | 2011-07-28 | 2014-06-10 | Michael H. Carney | Wallet-sized stand for mobile telephone |
USD688374S1 (en) | 2012-06-28 | 2013-08-20 | Viewitech Co., Ltd. | Device for measuring a parameter for manufacturing spectacle lens |
KR101203668B1 (en) | 2012-07-16 | 2012-11-23 | 장건상 | Smart phone stand |
USD694403S1 (en) | 2012-12-04 | 2013-11-26 | Keith Lensch | Eye drop bottle with positioning device |
USD694402S1 (en) | 2012-12-04 | 2013-11-26 | Keith Lensch | Positioning device for eye drop bottles |
TR201305176A2 (en) | 2013-05-02 | 2014-11-21 | Hueseyin Yetik | A system for visualizing body areas |
US9122131B2 (en) | 2013-06-05 | 2015-09-01 | Iridex Corporation | Microscope observation tube smart-phone adaptor |
US9131132B2 (en) | 2013-09-06 | 2015-09-08 | Transamerican Technologies International | Phone camera mount |
WO2015054672A1 (en) | 2013-10-10 | 2015-04-16 | The Regents Of The University Of California | Ocular cellscope apparatus |
USD737450S1 (en) | 2013-12-23 | 2015-08-25 | Ora, Inc. | Contoured eyecup for a portable ophthalmoscope |
KR20150084601A (en) | 2014-01-14 | 2015-07-22 | 엘지전자 주식회사 | Holder module and mobile terminal using the same |
US20150381794A1 (en) | 2014-06-30 | 2015-12-31 | Arthur Melvin Shulenberger | Viewing adapter for smartphone or similiar electronic device |
US9795293B2 (en) | 2014-08-22 | 2017-10-24 | Transamerican Technologies International | Universal adapter for camera-containing handheld device |
US10198720B2 (en) | 2014-12-22 | 2019-02-05 | Capital One Services, Llc | Mobile device stand |
JP6716604B2 (en) | 2015-01-19 | 2020-07-01 | スタツマヌ・アイシーピー・エーピーエスStatuManu ICP ApS | Method and apparatus for non-invasive assessment of intracranial pressure |
WO2016179370A1 (en) | 2015-05-05 | 2016-11-10 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Smartphone-based handheld ophthalmic examination devices |
USD814023S1 (en) | 2016-08-01 | 2018-03-27 | Rosa Burgman | Eye drop applicator |
WO2018045363A1 (en) | 2016-09-02 | 2018-03-08 | Gargeya Rishab | Screening method for automated detection of vision-degenerative diseases from color fundus images |
WO2018049190A1 (en) | 2016-09-08 | 2018-03-15 | University Of Southern California | Portable apparatus for imaging the eye |
-
2017
- 2017-12-11 US US15/837,712 patent/US11246483B2/en active Active
-
2022
- 2022-01-07 US US17/571,050 patent/US20220409047A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090109327A1 (en) * | 2007-10-24 | 2009-04-30 | Hon Hai Precision Industry Co., Ltd. | Camera module |
US20160073877A1 (en) * | 2012-02-02 | 2016-03-17 | Wei Su | Eye imaging apparatus and systems |
US20160209733A1 (en) * | 2015-01-19 | 2016-07-21 | Yoshiko Akai | Holder for mobile devices to take self-portraits or selfies remotely |
Also Published As
Publication number | Publication date |
---|---|
US20180160902A1 (en) | 2018-06-14 |
US11246483B2 (en) | 2022-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Caspi et al. | Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant | |
Petoe et al. | A second-generation (44-channel) suprachoroidal retinal prosthesis: interim clinical trial results | |
Van De Berg et al. | The vestibular implant: Opinion statement on implantation criteria for research 1 | |
WO2014182769A1 (en) | Automated and non-mydriatic fundus-perimetry camera for irreversible eye diseases | |
Oladehinde et al. | Visual functions of commercial drivers in relation to road accidents in Nigeria | |
Ciuffreda et al. | Proposed objective visual system biomarkers for mild traumatic brain injury | |
Ranno et al. | Changes in corneal parameters at confocal microscopy in treated glaucoma patients | |
Dumas et al. | Skull vibration-induced nystagmus test in unilateral superior canal dehiscence and otosclerosis: a vestibular Weber test | |
Ciuffreda et al. | Effect of binasal occlusion (BNO) on the visual-evoked potential (VEP) in mild traumatic brain injury (mTBI) | |
US20220409047A1 (en) | Apparatus for capturing an image of the eye | |
Yadav et al. | Effect of binasal occlusion (BNO) and base-in prisms on the visual-evoked potential (VEP) in mild traumatic brain injury (mTBI) | |
Pareja-Ríos et al. | Tele-ophthalmology for diabetic retinopathy screening: 8 years of experience | |
Gillmann et al. | Using sensors to estimate intraocular pressure: a review of intraocular pressure telemetry in clinical practice | |
Luu et al. | Visual field defects after stroke: A practical guide for GPs | |
Castellucci et al. | Which inner ear disorders lie behind a selective posterior semicircular canal hypofunction on video head impulse test? | |
Lew et al. | Auditory, vestibular, and visual impairments | |
Lew et al. | Dual sensory impairment (DSI) in traumatic brain injury (TBI)–An emerging interdisciplinary challenge | |
ES2943064T3 (en) | Virtual reality viewer for visual neurorehabilitation | |
Gannon et al. | Auditory and vestibular damage in head injuries at work | |
Hong et al. | Subjective visual vertical during eccentric rotation in patients with vestibular neuritis | |
Roodhooft | Summary of eye examinations of 284 patients with multiple sclerosis | |
Blanchard et al. | Common Occupational Therapy Vision Rehabilitation Interventions for Impaired and Low Vision Associated with Brain Injury. | |
Petoe et al. | A Second-Generation (44-Channel) Suprachoroidal Retinal Prosthesis: A Single-Arm Clinical Trial of Feasibility | |
Rezvani Amin et al. | The impact examination of the head tilt size on the subjective visual vertical (SVV) among the normal individuals with ages ranged from 18 to 35 years | |
Palomar-Mascaró | Rehabilitation of left homonymous hemianopia with adjacent palomar prism technique and visual therapy on line |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: ORA, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ABELSON, RICHARD;ABELSON, MARK B.;ANGJELI, ENDRI;AND OTHERS;SIGNING DATES FROM 20220523 TO 20220719;REEL/FRAME:064151/0903 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ORA LLC, MASSACHUSETTS Free format text: ENTITY CONVERSION;ASSIGNOR:ORA, INC.;REEL/FRAME:068149/0942 Effective date: 20240712 |